New database aims to unlock secrets of metabolic radiotherapy

NCT ID NCT04104529

Recruiting now Knowledge-focused Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 29 times

Summary

This study is creating a large database of clinical information and blood samples from 350 adults receiving metabolic radiotherapy for thyroid cancer, prostate cancer, or neuroendocrine tumors. The goal is to provide researchers with valuable data to better understand these treatments. No new therapies are being tested; instead, the focus is on collecting information for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
RECRUITING

Montpellier, 34298, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hopital Haut Lévêque
RECRUITING

Bordeaux, Aquitaine, France

Contact Email: •••••@•••••
Hôpital LaTimone
NOT_YET_RECRUITING

Marseille, Bouches Du Rhône, France

Contact Email: •••••@•••••
Institut Universitaire du Cancer de Toulouse
RECRUITING

Toulouse, 31100, France

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROENDOCRINE TUMORS PROSTATE CANCER THYROID CANCER